Thanks to the success of #STFUfriday, all suspects now reply “Am I free to go?" whenever Columbo asks if he can ask them one more question.
Thanks to the success of #STFUfriday, all suspects now reply “Am I free to go?" whenever Columbo asks if he can ask them one more question.
Come learn about disease data in Cape Town! 17-29 Jun, applications due 10 April.
• https://drive.google.com/file/d/1k_XLzAQLUI4lXA_IQ-1mnHGCzFJPTTbH/view
We published a fun, math-y analysis of epidemic "burnout" in #PNAS recently. It's stuff I've been thinking about for decades, but #ToddParsons and #DavidJDEarn made it happen. Also with @bbolker.bsky.social. Inspired to some extent by #JulietPulliam. https://www.pnas.org/eprint/VGKAKXZ4BQFDAYPJYPES/full
New preprint with the alternative title "What I wish I had known about delay distribution estimation in January 2020"
Featuring Poppy the puppy as a guest contributor!
Great collab w/ @sangwoopark, Andrei Akhmetzhanov, Kelly Charniga, Anne Cori, Nick Davies, @jd_mathbio, @sbfnk, Katie Gostic, Brian Grenfell, @nlinton_epi, @mlipsitch, Adrian Lison, Chris Overton, and Thomas Ward
I summarise our research on refining delay distribution estimates in epidemic modeling, a journey prompted by my general confusion. We explore and compare various approaches, drawing insights from simulations and Ebola virus disease outbreak data, and suggest paths for future improvements. Also featuring Poppy, the puppy, who is currently gnawing on my hand and occasionally archiving my emails.
At tomorrows #epinowcast community seminar (3pm GMT) we have Rebecca Borchering speaking on "Informing short-term forecasts of categorical trends in confirmed influenza hospital admissions in the US using real-time effective reproduction number estimates"
More here: https://www.epinowcast.org/seminars/2023-12-06-rebecca-borchering/
See the community post for async questions and the recording: https://community.epinowcast.org/t/community-seminar-2023-12-06-rebecca-borchering-informing-short-term-forecasts-of-categorical-trends-in-confirmed-influenza-hospital-admissions-in-the-us-using-real-time-effective-reproduction-number-estimates/209
The breakthrough class of GLP-1 and G-Agonist Drugs are exceeding lofty expectations beyond weight loss. Why?
https://erictopol.substack.com/p/when-the-breakthrough-g-agonists